Two Sigma Advisers’s Vanda Pharmaceuticals VNDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.82M | Buy |
|
|||||
|
2025
Q1 | $1.08M | Buy |
|
|||||
|
2024
Q4 | $749K | Buy |
|
|||||
|
2024
Q3 | $659K | Sell |
|
|||||
|
2024
Q2 | $1.21M | Sell |
|
|||||
|
2024
Q1 | $2.89M | Sell |
|
|||||
|
2023
Q4 | $3.74M | Buy |
|
|||||
|
2023
Q3 | $3.32M | Buy |
|
|||||
|
2023
Q2 | $4.12M | Buy |
|
|||||
|
2023
Q1 | $3.92M | Buy |
|
|||||
|
2022
Q4 | $3.35M | Buy |
|
|||||
|
2022
Q3 | $4.33M | Sell |
|
|||||
|
2022
Q2 | $6.38M | Sell |
|
|||||
|
2022
Q1 | $6.63M | Buy |
|
|||||
|
2021
Q4 | $8.59M | Buy |
|
|||||
|
2021
Q3 | $6.66M | Sell |
|
|||||
|
2021
Q2 | $8.8M | Buy |
|
|||||
|
2021
Q1 | $4.89M | Buy |
|
|||||
|
2020
Q4 | $3.54M | Sell |
|
|||||
|
2020
Q3 | $3.01M | Sell |
|
|||||
|
2020
Q2 | $5.05M | Buy |
|
|||||
|
2020
Q1 | $4.32M | Buy |
|
|||||
|
2019
Q4 | $6.27M | Buy |
|
|||||
|
2019
Q3 | $5.02M | Sell |
|
|||||
|
2019
Q2 | $5.92M | Buy |
|
|||||
|
2019
Q1 | $5.55M | Buy |
|
|||||
|
2018
Q4 | $5.98M | Sell |
|
|||||
|
2018
Q3 | $6.24M | Sell |
|
|||||
|
2018
Q2 | $5.72M | Buy |
|
|||||
|
2018
Q1 | $2.32M | Buy |
|
|||||
|
2017
Q4 | $1.63M | Sell |
|
|||||
|
2017
Q3 | $2.71M | Buy |
|
|||||
|
2017
Q2 | $2.4M | Buy |
|
|||||
|
2017
Q1 | $1.6M | Sell |
|
|||||
|
2016
Q4 | $2.56M | Buy |
|
|||||
|
2016
Q3 | $2.15M | Buy |
|
|||||
|
2016
Q2 | $617K | Buy |
|